Exact Sciences to Participate in Healthcare Conference
OREANDA-NEWS. Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in Baird's 2016 Global Healthcare Conference.
Kevin Conroy, the company's chairman and chief executive, will participate in a fireside chat at the conference on Wednesday, Sept. 7 at 10:15 a.m. ET in New York.
Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Cologuard is included in the American Cancer Society's (2014) colorectal cancer screening guidelines and the recommendations of the U.S. Preventive Services Task Force (2016). Stool DNA is included in the combined screening guidelines of the American Cancer Society/U.S. Multi-Society Task Force/American College of Radiology (2008) and the American College of Gastroenterology guidelines (2009).